|
|
Volumn 373, Issue 6, 2015, Pages 569-571
|
|
Targeted anti-anticoagulants
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANDEXANET ALFA;
ANTICOAGULANT AGENT;
ANTIVITAMIN K;
APIXABAN;
CIRAPARANTAG;
DABIGATRAN;
EDOXABAN;
FRESH FROZEN PLASMA;
IDARUCIZUMAB;
PROTHROMBIN COMPLEX;
RECOMBINANT BLOOD CLOTTING FACTOR 7A;
RIVAROXABAN;
WARFARIN;
BENZIMIDAZOLE DERIVATIVE;
BETA ALANINE;
MONOCLONAL ANTIBODY;
ANTICOAGULATION;
BLEEDING;
BRAIN HEMORRHAGE;
DRUG BINDING;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG SAFETY;
DRUG TARGETING;
EDITORIAL;
HUMAN;
MORTALITY;
NONHUMAN;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
THROMBIN TIME;
THROMBOSIS;
THROMBOSIS PREVENTION;
TREATMENT OUTCOME;
ANALOGS AND DERIVATIVES;
ANTAGONISTS AND INHIBITORS;
FEMALE;
HEMORRHAGE;
MALE;
ANTIBODIES, MONOCLONAL, HUMANIZED;
ANTICOAGULANTS;
BENZIMIDAZOLES;
BETA-ALANINE;
FEMALE;
HEMORRHAGE;
HUMANS;
MALE;
|
|
EID: 84938900144
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMe1506600 Document Type: Editorial |
|
Times cited : (34)
|
|
References (10)
|
